TGF-beta1 gene polymorphism in association with diabetic retinopathy susceptibility: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Liu, Lei ^a   Jiao, Jinghua ^b   Wang, Yu ^a   Wu, Jingyang ^a   Huang, Desheng ^a   Teng, Weiping ^a   Chen, Lei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ALLELE; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

DIABETIC RETINOPATHY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84899454342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094160     Document Type: Review

References (21)

1. Yamada M, Hiratsuka Y, Roberts CB, Pezzullo ML, Yates K, et al. (2010) Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol 17: 50-57.
2. Abhary S, Hewitt AW, Burdon KP, Craig JE (2009) A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 58:2137-2147.
3. Battegay EJ (1995) Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73: 333-346.
4. Nunes I, Munger J, HarpelJ G, Nagano Y, Shapiro R, et al. (1998) Structure and activation of the large latent transforming growth factor-beta complex. J Am Optom Assoc 69: 643-648.
5. Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H (1997) Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes 46 Suppl 2:S26-30. (Pubitemid 27377394)
6. Kim S, Glick A, Sporn M, Roberts AB (1989) Characterization of a promoter region of the human transforming growth factor-β1 gene. J Biol Chem 264: 402-408. (Pubitemid 19027618)
7. Beránek M, Kanková K, Benes P, Izakovicová- Hollá L, Znojil V, et al. (2002) Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 109:278-283. (Pubitemid 34437656)
8. Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A (2007) TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron Physiol 106: p69-75.
9. Paine SK, Basu A, Mondal LK, Sen A, Choudhuri S, et al. (2012) Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes. Mol Vis 18: 2749-2757.
10. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
11. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
12. DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28: 105-114. (Pubitemid 44937874)
13. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
14. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
15. Howell JE, McAnulty RJ (2006) TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets 7: 547-565. (Pubitemid 43744822)
16. Bran GM, Goessler UR, Schardt C, Hormann K, Riedel F, et al. (2010) Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars. Int J Mol Med 25: 915-921.
17. Wong TY, Poon P, Chow KM, Szeto CC, Cheung MK, et al. (2003) Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int 63: 1831-1835. (Pubitemid 36513330)
18. Saika S, Yamanaka O, Okada Y, Tanaka S, Miyamoto T, et al. (2009) TGF beta in fibroproliferative diseases in the eye. Front Biosci (Schol Ed) 1: 376-390.
19. Yamashita H, Tobari I, Sawa M, Hori S, Miyazono K, et al. (1997) Functions of the transforming growth factor-beta super family in eyes. Nippon Ganka Gakkai Zasshi 101: 927-947. (Pubitemid 28044725)
20. Chung EJ, Chun JN, Jung SA, Cho JW, Lee JH (2011) TGF-β-stimulated aberrant expression of class III β-tubulin via the ERK signaling pathway in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun 415: 367-372.
21. Zorena K, Malinowska E, Raczyńska D, Myśliwiec M, Raczyńska K (2013) Serum concentrations of transforming growth factor-Beta 1 in predicting the occurrence of diabetic retinopathy in juvenile patients with type 1 diabetes mellitus. J Diabetes Res 2013: 614908.